Matthew Beatty
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 6
- Immune cells in cancer 4
- Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 6
- Co-authors
- Shari Pilon‐Thomas (18 shared papers)Amod A. Sarnaik (7 shared papers)Krithika N. Kodumudi (3 shared papers)MacLean Hall (7 shared papers)Dominique Abrahams (3 shared papers)John E. Mullinax (5 shared papers)Arig Ibrahim‐Hashim (2 shared papers)Dario Livio Longo (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Molecular Therapy (1 paper)Journal of Immunotherapy (1 paper)Blood (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Matthew Beatty
23 papers receiving 318 citations
Peers
Comparison fields: 5 of 61
- Immunology 170
- Oncology 161
- Cancer Research 46
- Biotechnology 16
- Pulmonary and Respiratory Medicine 44
Countries citing papers authored by Matthew Beatty
This map shows the geographic impact of Matthew Beatty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Beatty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Beatty more than expected).
Fields of papers citing papers by Matthew Beatty
This network shows the impact of papers produced by Matthew Beatty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Beatty. The network helps show where Matthew Beatty may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Beatty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 119 | |
| 2 | 2018 | 35 | |
| 3 | 2021 | 34 | |
| 4 | 2020 | 30 | |
| 5 | 2021 | 26 | |
| 6 | 2019 | 14 | |
| 7 | 2023 | 10 | |
| 8 | 2021 | 8 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 7 | |
| 11 | 1996 | 6 | |
| 12 | 2024 | 6 | |
| 13 | 2025 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2018 | 1 |
About Matthew Beatty
Matthew Beatty is a scholar working on Immunology, Oncology, Surgery, Molecular Biology and Biomedical Engineering, having authored 27 papers that have together received 323 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers), Immune cells in cancer (4 papers), Cancer Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Immunology (170 citations), Oncology (161 citations), Cancer Research (46 citations), Biotechnology (16 citations) and Pulmonary and Respiratory Medicine (44 citations). Matthew Beatty has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Shari Pilon‐Thomas, Amod A. Sarnaik, Krithika N. Kodumudi, MacLean Hall, Dominique Abrahams, John E. Mullinax, Arig Ibrahim‐Hashim, Dario Livio Longo, Verónica Estrella and Patrick Innamarato. Their work appears in journals such as Frontiers in Immunology, Journal for ImmunoTherapy of Cancer, Molecular Therapy, Journal of Immunotherapy and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.